SEC Form 424B3 filed by SBC Medical Group Holdings Incorporated
$SBC
Medical/Nursing Services
Health Care
Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
3 - SBC Medical Group Holdings Inc (0001930313) (Issuer)
3/A - SBC Medical Group Holdings Inc (0001930313) (Issuer)
4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)
OrangeTwist, a leading U.S. med spa platform delivering cutting-edge aesthetic and wellness treatments through a hospitality-driven clinical experience, has announced a strategic alliance and minority investment with SBC Medical Group Holdings Incorporated (NASDAQ:SBC) as part of its accelerated national growth strategy. The collaboration marks a significant milestone for OrangeTwist, enabling new clinical, operational, and technological synergies with a global leader in medical services and clinic operations. In conjunction with this announcement, OrangeTwist has acquired six additional med spa locations in Colorado and Nevada, expanding its footprint to 24 locations across 6 states, inc
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the completion of a strategic minority equity investment and the establishment of a structured collaboration framework with OrangeTwist, a leading U.S.-based MedSpa chain, alongside its longstanding institutional shareholders, Hildred Capital and Athyrium Capital. This transaction marks SBC Medical's formal entry into the United States—a key global market for medical aesthetics—and represents a major milestone in the Company's broader global expansion strategy. For more details,
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) (the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced an updated capital strategy for future growth, which includes the filing of a Form S-3 registration statement with the U.S. Securities and Exchange Commission (SEC) and a share repurchase program. The Company remains committed to maximizing corporate value and improving liquidity of its common stock while carefully considering market impact. Effectiveness of Form S-3 (Shelf Registration) The Company's Form S-3 Registration Statement, which was declared effective by the SEC on December 30
8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)
424B3 - SBC Medical Group Holdings Inc (0001930313) (Filer)
8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company's strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center
IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of
SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)
SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)
SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 mill
SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it will release its Q3 2025 financial results on Friday, November 14, 2025, before the U.S. market opens. The Company will hold a Earnings Call on Monday, November 17, 2025 at 5:00 p.m. Eastern Time to discuss the financial results and take questions live. Please register in advance for the conference using the link provided below. https://edge.media-server.com/mmc/p/e2znwqtx It will automatically direct you to the registration page for "SBC Q3 2025 Financial Resu
SBC Medical Group Holdings Incorporated (NASDAQ:SBC, "SBC Medical" or the "Company")), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced its financial results for the second quarter of fiscal year 2025 (three months ended June 30, 2025) and for the first half of fiscal year 2025 (six months ended June 30, 2025). Second Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $15 million, representing a 47% year-over-year decrease. Net Income attributable to SBC Medical Group was $2.5 million, representing an 87% year-over-year decrease.